ARCHIVES

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

This article is from The Cancer Letter archive.

Vol. 06 No. 13 | March 28, 1980

Download PDF Visit The Full Archive

Related Articles

ImClone: Waksals To Pay $5 Million To Settle With SEC.

January 28, 2005

Mouse Strains Now Available From NCI

March 18, 1983

DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable”

April 23, 1982

No Cancer Letter for Two Weeks

August 13, 1993

NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer

May 8, 1992

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014